InChI=1S/C40H62N8O6S/c1- 19(2) 15- 27- 35(50) 45- 31(21(5) 6) 38(53) 47- 32(22(7) 8) 39(54) 48- 33(23(9) 10) 40- 44- 29(18- 55- 40) 36(51) 46- 30(20(3) 4) 37(52) 43- 28(34(49) 42- 27) 16- 24- 17- 41- 26- 14- 12- 11- 13- 25(24) 26/h11- 14,17,19- 23,27- 33,40- 41,44H,15- 16,18H2,1- 10H3,(H,42,49) (H,43,52) (H,45,50) (H,46,51) (H,47,53) (H,48,54) /t27- ,28+,29+,30- ,31+,32- ,33+,40?/m1/s1 |
QZNGYMKAHFFKCJ-ZBQZSICZSA-N |
O=C1[C@H] (NC([C@@H] (NC([C@@H] (CC(C) C) NC(=O) [C@@H] (NC([C@@H] (C(C) C) NC(=O) [C@@H] 2CSC(N2) [C@H] (C(C) C) N1) =O) CC=3C=4C=CC=CC4NC3) =O) C(C) C) =O) C(C) C |
|
Rattus norvegicus
(NCBI:txid10116)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via peptide antibiotic )
|
|
View more via ChEBI Ontology
(1R,4R,7S,10R,13S,16R,19S)- 7- [(1H- indol- 3- yl)methyl]- 10- (2- methylpropyl)- 4,13,16,19- tetra(propan- 2- yl)- 21- thia- 3,6,9,12,15,18,23- heptaazabicyclo[18.2.1]tricosane- 2,5,8,11,14,17- hexone
|
27466123
|
PubMed citation
|
Europe PMC
|
|